Furthermore, silencing of FASN induced upregulation of the fatty acid transporter LPL and downregulation of the fatty acid transporter CD36 in the four human HCC cell lines (Figure 6, Figures S2–S4). This evidence concerns the gene FASN and hepatocellular carcinoma.